| # | Drug | Count |
|---|---|---|
| 0 | ATEZOLIZUMAB | 12 |
| 1 | BEVACIZUMAB | 12 |
| 2 | RIBOCICLIB | 12 |
| 3 | ADALIMUMAB | 9 |
| 4 | CIPROFLOXACIN HYDROCHLORIDE | 9 |
| 5 | FULVESTRANT | 9 |
| 6 | LETROZOLE | 9 |
| 7 | METRONIDAZOLE | 9 |
| 8 | PEMBROLIZUMAB | 9 |
| 9 | CAPECITABINE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LACTULOSE SOLUTION USP, 10 G/15 ML | 1 | 0.0099 |
| 1 | SACCHAROMYCES CEREVISIAE | 6 | 0.0065 |
| 2 | PLATINUM | 2 | 0.0038 |
| 3 | VIMSELTINIB | 1 | 0.0018 |
| 4 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 5 | EPCORITAMAB-BYSP | 2 | 0.0015 |
| 6 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 7 | 12%AZELAIC ACID | 1 | 0.0012 |
| 8 | DATOPOTAMAB DERUXTECAN | 1 | 0.0012 |
| 9 | NIROGACESTAT | 1 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Non-Standardized Fungal Allergenic Extract [EPC] | 6 | 0.0028 |
| 1 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 2 | Ergot Derivative [EPC] | 3 | 0.0006 |
| 3 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 4 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 5 | Estrogen Receptor Antagonist [EPC] | 9 | 0.0002 |
| 6 | Antiparasitic [EPC] | 1 | 0.0002 |
| 7 | Pediculicide [EPC] | 1 | 0.0002 |
| 8 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 9 | 0.0001 |